PolyPeptide Group AG
SIX:PPGN
PolyPeptide Group AG
SIX:PPGN
Price:
24.75
CHF
-0.6%
Market Closed
Market Cap:
CHf820m
PolyPeptide Group AG
Research & Development
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
PolyPeptide Group AG
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
PolyPeptide Group AG
SIX:PPGN
|
Research & Development
-€2.3m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Bachem Holding AG
SIX:BANB
|
Research & Development
-CHf10.2m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-17%
|
|
|
Siegfried Holding AG
SIX:SFZN
|
Research & Development
-CHf46.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Lonza Group AG
SIX:LONN
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Tecan Group AG
SIX:TECN
|
Research & Development
-CHf51.4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
SKAN Group AG
SIX:SKAN
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
PolyPeptide Group AG
Glance View
PolyPeptide Group AG is a contract development and manufacturing organization for clinical and approved commercial-stage peptide drug substances used in peptide-based therapeutics. The company is headquartered in Zug, Zug and currently employs 1,041 full-time employees. The company went IPO on 2021-04-29.
PPGN Intrinsic Value
HIDDEN
See Also
What is PolyPeptide Group AG's Research & Development?
Research & Development
-2.3m
EUR
-2.3m
EUR
Based on the financial report for Dec 31, 2025, PolyPeptide Group AG's Research & Development amounts to -2.3m EUR.
What is PolyPeptide Group AG's Research & Development growth rate?
Research & Development CAGR 5Y
-12%
-12%
Over the last year, the Research & Development growth was -108%. The average annual Research & Development growth rates for PolyPeptide Group AG have been -22% over the past three years , -12% over the past five years .
